A Conversation with Siemens at BOMA
The BOMA Conference in Denver, Colorado, brought together medical real estate industry leaders for three days filled with insightful conversations and engaging panels. Overall, the tone was cautiously optimistic, with many industry experts anticipating that medical real estate deal volume will pick up in the second half of the year. Several themes circulated throughout the conference across the panels and attendees: the slower M&A market in the first half of 2025, the rise of new construction and the state of the lending market. Why has M&A volume dropped? The LevinPro HC team spoke with Edward Finkenstaedt, Senior Risk Manager and Team Leader of Siemens Financial Services, who... Read More »
Private Equity Firm HCAP Partners Acquires First Choice Mobile Radiology Services
HCAP Partners has acquired First Choice Mobile Radiology Services (FCMR) as the first acquisition under its new mobile imaging platform, Integrated Diagnostic Services (IDS). This strategic transaction represents a significant development in the mobile diagnostic imaging sector, which has seen considerable activity in 2024-2025. The acquisition aligns with broader healthcare trends showing a shift toward outpatient and mobile diagnostic settings. The acquisition was announced on April 22, 2025. This acquisition is part of HCAP’s strategy to expand access to mobile diagnostics for senior care and home health populations through its IDS platform. IDS aims to build a regional platform... Read More »
Revelstoke Capital Partners Recapitalizes AOM Infusion: Strategic Investment in High-Growth Specialty Infusion Market
Revelstoke Capital Partners announced in April 2025 a recapitalization of AOM Infusion, with the transaction having closed on March 19, 2025. This investment marks the ninth from Revelstoke Capital Partners Fund III. Ridgemont Equity Partners, which previously owned AOM Infusion, will retain a minority equity position following this recapitalization. Financial terms of the deal were not disclosed. This report analyzes the transaction in the context of the rapidly growing specialty infusion market, which is experiencing significant private equity interest due to the shift toward home and ambulatory care settings, an aging population and expanding pipeline of infusible therapies. About AOM... Read More »
CVS Subsidiary Sells Its Infusion Care Assets to KabaFusion
On May 19, Coram Infusion Services, the infusion therapy branch of CVS, reported that it was selling infusion services assets to KabaFusion. The transaction includes six locations that serve as pharmacies and ambulatory infusion suites. KabaFusion, a portfolio company of Novo Holdings, provides acute and home infusion services in more than 40 states, specializing in intravenous immunoglobulin and other home infusion therapies. The company serves patients in 45 states through its nationwide network of home infusion pharmacies, alternative infusion sites and home health agencies. The transaction will expand KabaFusion’s ability to serve a growing number of patients nationwide and... Read More »
Flourish Research Continues Expansion with CARE Deal
Flourish Research has announced the acquisition of the Center for Advanced Research & Education (CARE) based in Gainesville, Georgia. CARE is a multi-therapeutic research facility dedicated to advancing innovation in healthcare through conducting phase I-IV clinical trials. Founded in 1998, CARE has conducted more than 150 clinical trials across multiple therapeutic areas. Based in New York City, Flourish Research is a fully integrated clinical trial organization in North America. The company has sites throughout Alabama, California, Florida, Illinois, North Carolina, Pennsylvania and Texas. Flourish has conducted more than 3,700 trials across more than 15 therapeutic areas and more... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
